Gene diagnostics at Genome Center of Eastern Finland

Genome Center of University of Eastern Finland has provided diagnostic test for monogenic diseases and farmacogenomics since 2004. During these years we have keep our analysis methods up-to-date and improved our reporting and quality management policies. We are committed to continuosly improve our procedures to serve our customers as appropriately as possible.

What's new in analytics?

7.5.19
Our new prices for 1.5.2019-30.4.2020. Pricelist in finnish. You can find prices also from request forms.

16.3.18
Gene diagnostics laboratory is now accredited laboratory no. T321 by FINAS Finnish Accreditation Service, accreditation requirement SFS-EN ISO 15189:2013. Detailed information about the scope is available on the website: ’FINAS’.

New polymerase enzyme is now validated. Delays in ’Polycystic kidney disease’ and 21-hydroxylase deficiency are over.

21.8.17
One manufacturer has discontinued manufacturing of essential polymerase enzyme.  This might cause slight delays in ’Polycystic kidney disease’ and ’21-hydroxylase deficiency’ analysis in the near future.

23.2.17
Deletion analysis (MLPA) of PKHD1 gene added to ’Polycystic kidney disease analysis

23.2.17
Deletion analysis (MLPA) of GBA gene added to ’Gaucher's disease

Quality management

Gene diagnostics laboratory is accredited laboratory no. T321 by FINAS Finnish Accreditation Service, accreditation requirement SFS-EN ISO 15189:2013. Detailed information about the scope is available on the website: ’FINAS

Continuous maintenance and development of our operations comprises of personnel, facilities, equipment, methods, documentation, and to determining customer needs.